$PERI
Perion Network Ltd Stock $peri

$peri Overview Financials Valuation SEC Filings Company Website

2023 Q4 Form 20-F Financial Statement

#000117891324001251 Filed on April 08, 2024

Income Statement

Concept	2023 Q4	2023	2022 Q4
Revenue	$234.2M	$743.2M	$209.7M
YoY Change	11.71%	16.07%	32.72%
Cost Of Revenue	$154.5M	$470.8M	$9.390M
YoY Change	1545.18%	1448.39%	28.31%
Gross Profit	$79.75M	$272.4M	$200.3M
YoY Change	-60.18%	-55.34%	32.94%
Gross Profit Margin	34.05%	36.65%	95.52%
Selling, General & Admin	$25.14M	$89.79M	$24.02M
YoY Change	4.68%	12.48%	1.43%
% of Gross Profit	31.52%	32.96%	11.99%
Research & Development	$8.714M	$33.07M	$9.289M
YoY Change	-6.19%	-3.94%	0.48%
% of Gross Profit	10.93%	12.14%	4.64%
Depreciation & Amortization	$3.901M	$14.09M	$3.741M
YoY Change	4.28%	1.84%	3.97%
% of Gross Profit	4.89%	5.17%	1.87%
Operating Expenses	$39.86M	$155.6M	$37.05M
YoY Change	7.61%	-70.69%	1.44%
Operating Profit	$39.88M	$116.7M	$163.2M
YoY Change	-75.57%	6.94%	43.02%
Interest Expense	$6.262M	$20.95M	$1.976M
YoY Change	216.9%	365.37%	-524.95%
% of Operating Profit	15.7%	17.95%	1.21%
Other Income/Expense, Net		$20.95M
YoY Change		365.37%
Pretax Income	$46.15M	$137.7M	$43.16M
YoY Change	6.91%	21.14%	112.32%
Income Tax	$6.745M	$20.28M	$4.487M
% Of Pretax Income	14.62%	14.73%	10.4%
Net Earnings	$39.40M	$117.4M	$38.68M
YoY Change	1.87%	18.33%	118.58%
Net Earnings / Revenue	16.82%	15.8%	18.45%
Basic Earnings Per Share		$2.49
Diluted Earnings Per Share	$0.78	$2.35	$0.79
COMMON SHARES
Basic Shares Outstanding	47.99M shares	47.13M shares	46.17M shares
Diluted Shares Outstanding		50.07M shares

Balance Sheet

Concept	2023 Q4	2023	2022 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments	$472.7M	$472.7M	$429.6M
YoY Change	10.02%	10.02%	33.57%
Cash & Equivalents	$187.6M	$187.6M	$176.2M
Short-Term Investments	$285.1M	$285.1M	$253.4M
Other Short-Term Assets	$22.37M	$22.37M	$13.34M
YoY Change	67.66%	67.66%	45.61%
Inventory
Prepaid Expenses
Receivables	$231.5M	$231.5M	$160.5M
Other Receivables	$0.00	$0.00	$0.00
Total Short-Term Assets	$726.6M	$726.6M	$603.5M
YoY Change	20.4%	20.4%	35.25%
LONG-TERM ASSETS
Property, Plant & Equipment	$9.788M	$9.788M	$3.611M
YoY Change	171.06%	-28.77%	-77.13%
Goodwill	$248.0M		$195.5M
YoY Change	26.82%		3.31%
Intangibles	$88.65M		$51.66M
YoY Change	71.59%		-8.88%
Long-Term Investments
YoY Change
Other Assets	$2.902M	$2.902M	$49.00K
YoY Change	5822.45%	-50.21%	-99.08%
Total Long-Term Assets	$350.7M	$350.7M	$266.8M
YoY Change	31.46%	31.46%	-0.11%
TOTAL ASSETS
Total Short-Term Assets	$726.6M	$726.6M	$603.5M
Total Long-Term Assets	$350.7M	$350.7M	$266.8M
Total Assets	$1.077B	$1.077B	$870.2M
YoY Change	23.79%	23.79%	22.01%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$217.2M	$217.2M	$155.9M
YoY Change	39.35%	39.35%	44.67%
Accrued Expenses	$46.83M	$46.83M	$37.87M
YoY Change	23.67%	12.13%	-13.83%
Deferred Revenue
YoY Change
Short-Term Debt	$0.00	$0.00	$0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities	$340.0M	$340.0M	$234.6M
YoY Change	44.93%	44.93%	21.11%
LONG-TERM LIABILITIES
Long-Term Debt	$0.00	$0.00	$0.00
YoY Change
Other Long-Term Liabilities	$19.09M	$19.09M	$11.78M
YoY Change	62.02%	-63.62%	-77.58%
Total Long-Term Liabilities	$19.09M	$19.09M	$11.78M
YoY Change	62.02%	-63.62%	-77.58%
TOTAL LIABILITIES
Total Short-Term Liabilities	$340.0M	$340.0M	$234.6M
Total Long-Term Liabilities	$19.09M	$19.09M	$11.78M
Total Liabilities	$359.1M	$359.1M	$287.1M
YoY Change	25.09%	25.09%	16.57%
SHAREHOLDERS EQUITY
Retained Earnings	$188.2M		$70.79M
YoY Change	165.87%		-348.9%
Common Stock	$531.0M		$513.9M
YoY Change	3.33%		3.5%
Preferred Stock
YoY Change
Treasury Stock (at cost)	$1.002M		$1.002M
YoY Change	0.0%		0.0%
Treasury Stock Shares			115.3K shares
Shareholders Equity	$718.1M	$718.1M	$583.1M
YoY Change
Total Liabilities & Shareholders Equity	$1.077B	$1.077B	$870.2M
YoY Change	23.79%	23.79%	22.01%

Cashflow Statement

Concept	2023 Q4	2023	2022 Q4
OPERATING ACTIVITIES
Net Income	$39.40M	$117.4M	$38.68M
YoY Change	1.87%	18.33%	118.58%
Depreciation, Depletion And Amortization	$3.901M	$14.09M	$3.741M
YoY Change	4.28%	1.84%	3.97%
Cash From Operating Activities	$50.22M	$155.5M	$38.17M
YoY Change	31.56%	27.3%	32.37%
INVESTING ACTIVITIES
Capital Expenditures	$281.0K	$784.0K	$267.0K
YoY Change	5.24%	-25.9%	-302.27%
Acquisitions		$101.9M
YoY Change		965.01%
Other Investing Activities	-$60.42M	-$132.6M	-$34.40M
YoY Change	75.65%	189.64%	-82.09%
Cash From Investing Activities	-$60.70M	-$133.4M	-$34.67M
YoY Change	75.1%	184.85%	-81.97%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net	$95.00K	$2.433M
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	95.00K	-10.82M	1.392M
YoY Change	-93.18%	232.2%	-99.19%
NET CHANGE
Cash From Operating Activities	50.22M	155.5M	38.17M
Cash From Investing Activities	-60.70M	-133.4M	-34.67M
Cash From Financing Activities	95.00K	-10.82M	1.392M
Net Change In Cash	-10.39M	11.29M	4.895M
YoY Change	-312.28%	-84.32%	-39.46%
FREE CASH FLOW
Cash From Operating Activities	$50.22M	$155.5M	$38.17M
Capital Expenditures	$281.0K	$784.0K	$267.0K
Free Cash Flow	$49.94M	$154.7M	$37.90M
YoY Change	31.75%	27.77%	30.84%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2023Q4	us-gaap	Assets Current AssetsCurrent	726586000	usd
CY2022Q4	us-gaap	Assets Current AssetsCurrent	603458000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3179000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3611000	usd
CY2021Q4	us-gaap	Stockholders Equity StockholdersEquity	466960000	usd
CY2022	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	11570000	usd
CY2022	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	5833000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-454000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	99225000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	583134000	usd
CY2023	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	14668000	usd
CY2023	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	2433000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	117413000	usd
CY2023	us-gaap	Net Income Loss NetIncomeLoss	117413000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	99225000	usd
CY2021	peri	Accrued Severance Pay Net AccruedSeverancePayNet	663000	usd
CY2023	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	5547000	usd
CY2022	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	12000	usd
CY2021	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	2781000	usd
CY2022	peri	Increase Decrease In Operating Lease Rightofuse Assets IncreaseDecreaseInOperatingLeaseRightofuseAssets	1104000	usd
CY2021	peri	Increase Decrease In Operating Lease Rightofuse Assets IncreaseDecreaseInOperatingLeaseRightofuseAssets	8510000	usd
CY2023	peri	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	3966000	usd
CY2022	peri	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	1909000	usd
CY2021	peri	Increase Decrease In Operating Lease Liabilities IncreaseDecreaseInOperatingLeaseLiabilities	8643000	usd
CY2023	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	6878000	usd
CY2022	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	48191000	usd
CY2021	us-gaap	Increase Decrease In Accounts Payable Trade IncreaseDecreaseInAccountsPayableTrade	35222000	usd
CY2023	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	-2917000	usd
CY2022	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	9320000	usd
CY2021	us-gaap	Increase Decrease In Accrued Liabilities And Other Operating Liabilities IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities	21446000	usd
CY2023	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1093000	usd
CY2022	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1474000	usd
CY2023	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	253400000	usd
CY2022	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	217200000	usd
CY2021	us-gaap	Proceeds From Sale Maturity And Collection Of Shortterm Investments ProceedsFromSaleMaturityAndCollectionOfShorttermInvestments	12700000	usd
CY2023	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	207450000	usd
CY2022	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	253400000	usd
CY2021	us-gaap	Payments To Acquire Short Term Investments PaymentsToAcquireShortTermInvestments	217200000	usd
CY2023	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	101921000	usd
CY2022	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	9570000	usd
CY2021	us-gaap	Payments To Acquire Businesses Net Of Cash Acquired PaymentsToAcquireBusinessesNetOfCashAcquired	38438000	usd
CY2023	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-133354000	usd
CY2022	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-46816000	usd
CY2021	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-243470000	usd
CY2023	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	2433000	usd
CY2021	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	6898000	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	13256000	usd
CY2022	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	9091000	usd
CY2021	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	8333000	usd
CY2023	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-10823000	usd
CY2022	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	-3258000	usd
CY2021	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	229054000	usd
CY2023	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	141000	usd
CY2022	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-59000	usd
CY2021	us-gaap	Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	-33000	usd
CY2023	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	11427000	usd
CY2022	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	71986000	usd
CY2021	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect	56657000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	177521000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105535000	usd
CY2020Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	48878000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188948000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	177521000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105535000	usd
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	187609000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	176226000	usd
CY2021Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	104446000	usd
CY2023Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1339000	usd
CY2022Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1295000	usd
CY2021Q4	us-gaap	Restricted Cash And Cash Equivalents RestrictedCashAndCashEquivalents	1089000	usd
CY2023Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	188948000	usd
CY2022Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	177521000	usd
CY2021Q4	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	105535000	usd
CY2023	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	18030000	usd
CY2022	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	7689000	usd
CY2023	us-gaap	Interest Paid Net InterestPaidNet	6000	usd
CY2022	us-gaap	Interest Paid Net InterestPaidNet	5000	usd
CY2021	us-gaap	Interest Paid Net InterestPaidNet	203000	usd
CY2022	peri	Creation Of Right Of Use Assets CreationOfRightOfUseAssets	2085000	usd
CY2023	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	2000	usd
CY2022	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	-47000	usd
CY2021	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	45000	usd
CY2023	peri	Short Term Deposits Average Rate ShortTermDepositsAverageRate	0.0667	pure
CY2022	peri	Short Term Deposits Average Rate ShortTermDepositsAverageRate	0.0382	pure
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2134000	usd
CY2023	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	1133000	usd
CY2022	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	210000	usd
CY2021	us-gaap	Provision For Doubtful Accounts ProvisionForDoubtfulAccounts	82000	usd
CY2023	us-gaap	Severance Costs1 SeveranceCosts1	3206000	usd
CY2022	us-gaap	Severance Costs1 SeveranceCosts1	2809000	usd
CY2021	us-gaap	Severance Costs1 SeveranceCosts1	2612000	usd
CY2023	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	1006000	usd
CY2022	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	865000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Two FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo	13502000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Three FiniteLivedIntangibleAssetsAmortizationExpenseYearThree	12175000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Four FiniteLivedIntangibleAssetsAmortizationExpenseYearFour	12047000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense After Year Five FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive	23291000	usd
CY2023Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	159279000	usd
CY2023Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	20000	usd
CY2023Q4	peri	Fair Value Liabilities Measured On Recurring Basis Contingent Consideration In Connection To Acquisitions FairValueLiabilitiesMeasuredOnRecurringBasisContingentConsiderationInConnectionToAcquisitions	69715000	usd
CY2022Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	63934000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	29591000	usd
CY2023Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	25228000	usd
CY2022Q4	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	25980000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3179000	usd
CY2022Q4	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	3611000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	195527000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	247975000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	51664000	usd
CY2023	peri	Finite Lived Intangible Assets Net Measurement Period Adjustments During Period FiniteLivedIntangibleAssetsNetMeasurementPeriodAdjustmentsDuringPeriod	49436000	usd
CY2023	peri	Finite Lived Intangible Assets Net Amortization FiniteLivedIntangibleAssetsNetAmortization	12448000	usd
CY2023Q4	us-gaap	Foreign Currency Cash Flow Hedge Asset At Fair Value ForeignCurrencyCashFlowHedgeAssetAtFairValue	234000	usd
CY2022Q4	us-gaap	Foreign Currency Cash Flow Hedge Asset At Fair Value ForeignCurrencyCashFlowHedgeAssetAtFairValue	7000	usd
CY2023Q4	us-gaap	Foreign Currency Cash Flow Hedge Liability At Fair Value ForeignCurrencyCashFlowHedgeLiabilityAtFairValue	20000	usd
CY2022Q4	us-gaap	Foreign Currency Cash Flow Hedge Liability At Fair Value ForeignCurrencyCashFlowHedgeLiabilityAtFairValue	239000	usd
CY2023	us-gaap	Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax	214000	usd
CY2022	us-gaap	Unrealized Gain Loss On Foreign Currency Derivatives Net Before Tax UnrealizedGainLossOnForeignCurrencyDerivativesNetBeforeTax	232000	usd
CY2023Q4	us-gaap	Foreign Currency Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	0	usd
CY2022Q4	us-gaap	Foreign Currency Derivative Instruments Not Designated As Hedging Instruments Asset At Fair Value ForeignCurrencyDerivativeInstrumentsNotDesignatedAsHedgingInstrumentsAssetAtFairValue	18000	usd
CY2023Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	0	usd
CY2022Q4	us-gaap	Derivative Fair Value Of Derivative Net DerivativeFairValueOfDerivativeNet	31000	usd
CY2023	us-gaap	Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet	-1373000	usd
CY2022	us-gaap	Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet	-1023000	usd
CY2021	us-gaap	Gain Loss On Foreign Currency Derivatives Recorded In Earnings Net GainLossOnForeignCurrencyDerivativesRecordedInEarningsNet	191000	usd
CY2022Q4	us-gaap	Property Plant And Equipment And Finance Lease Right Of Use Asset After Accumulated Depreciation And Amortization PropertyPlantAndEquipmentAndFinanceLeaseRightOfUseAssetAfterAccumulatedDepreciationAndAmortization	344000	usd
CY2023Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y10D
CY2023Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0505	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Next Twelve Months LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths	4605000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Three LesseeOperatingLeaseLiabilityPaymentsDueYearThree	777000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due LesseeOperatingLeaseLiabilityPaymentsDue	8233000	usd
CY2023Q4	us-gaap	Lessee Operating Lease Liability Undiscounted Excess Amount LesseeOperatingLeaseLiabilityUndiscountedExcessAmount	587000	usd
CY2023Q4	us-gaap	Operating Lease Liability OperatingLeaseLiability	7646000	usd
CY2023	peri	Operating Lease Rent Expense Sublease Rentals OperatingLeaseRentExpenseSubleaseRentals	5646000	usd
CY2023	us-gaap	Operating Lease Expense OperatingLeaseExpense	1993000	usd
CY2022	us-gaap	Operating Lease Expense OperatingLeaseExpense	2846000	usd
CY2021	us-gaap	Operating Lease Expense OperatingLeaseExpense	4441000	usd
CY2023	us-gaap	Sublease Income SubleaseIncome	3598000	usd
CY2022	us-gaap	Sublease Income SubleaseIncome	2533000	usd
CY2021	us-gaap	Sublease Income SubleaseIncome	2838000	usd
CY2023	peri	Cash Paid For Measurement Of Lease Liabilities CashPaidForMeasurementOfLeaseLiabilities	6191000	usd
CY2021	peri	Cash Paid For Measurement Of Lease Liabilities CashPaidForMeasurementOfLeaseLiabilities	8465000	usd
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod	P7Y
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	3064674	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Expirations In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExpirationsInPeriodWeightedAverageExercisePrice	0.12
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber	2493281	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	0.84
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P66Y8M12D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	74862000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber	349648	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice	5.4
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1	P2Y4M17D
CY2023Q4	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1	8905000	usd
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber	2489358	shares
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice	0.89
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Remaining Contractual Term1 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageRemainingContractualTerm1	P73Y7M2D
CY2023Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Aggregate Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingAggregateIntrinsicValue	140704000	usd
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Outstanding Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfOutstandingOptions	2493281	shares
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageRemainingContractualTerm2	P66Y8M12D
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Outstanding Options Weighted Average Exercise Price Beginning Balance1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeOutstandingOptionsWeightedAverageExercisePriceBeginningBalance1	0.84
CY2023Q4	us-gaap	Share Based Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Number Of Exercisable Options ShareBasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeNumberOfExercisableOptions	349648	shares
CY2023	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2	P2Y4M17D
CY2023Q4	us-gaap	Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Exercise Price1 SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageExercisePrice1	5.4
CY2022	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	11570000	usd
CY2021	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	6985000	usd
CY2023	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	20728000	usd
CY2022	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	4993000	usd
CY2021	us-gaap	Investment Income Interest And Dividend InvestmentIncomeInterestAndDividend	539000	usd
CY2023	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	21875000	usd
CY2022	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	4993000	usd
CY2023	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	567000	usd
CY2022	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	264000	usd
CY2021	us-gaap	Foreign Currency Transaction Loss Before Tax ForeignCurrencyTransactionLossBeforeTax	528000	usd
CY2023	us-gaap	Accretion Expense AccretionExpense	0	usd
CY2022	us-gaap	Accretion Expense AccretionExpense	0	usd
CY2021	us-gaap	Accretion Expense AccretionExpense	119000	usd
CY2023	peri	Bank Charges And Other BankChargesAndOther	357000	usd
CY2022	peri	Bank Charges And Other BankChargesAndOther	227000	usd
CY2021	peri	Bank Charges And Other BankChargesAndOther	473000	usd
CY2023	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	924000	usd
CY2022	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	491000	usd
CY2021	us-gaap	Other Nonoperating Expense OtherNonoperatingExpense	1120000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	20951000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-581000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	129676000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	106634000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Domestic IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic	38854000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	8015000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	113664000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	45315000	usd
CY2023	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	21623000	usd
CY2022	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	16758000	usd
CY2023	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	-611000	usd
CY2022	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	-794000	usd
CY2021	us-gaap	Tax Adjustments Settlements And Unusual Provisions TaxAdjustmentsSettlementsAndUnusualProvisions	1476000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20278000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14439000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6609000	usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	19466000	usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	14378000	usd
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	8060000	usd
CY2023	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	812000	usd
CY2022	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	61000	usd
CY2021	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	-1451000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20278000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14439000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6609000	usd
CY2022	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	15938000	usd
CY2021	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	7447000	usd
CY2023	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-1594000	usd
CY2022	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-860000	usd
CY2021	us-gaap	Deferred Federal Income Tax Expense Benefit DeferredFederalIncomeTaxExpenseBenefit	-980000	usd
CY2023	peri	Deferred Federal Tax Adjustments Settlements And Unusual Provisions DeferredFederalTaxAdjustmentsSettlementsAndUnusualProvisions	-46000	usd
CY2022	peri	Deferred Federal Tax Adjustments Settlements And Unusual Provisions DeferredFederalTaxAdjustmentsSettlementsAndUnusualProvisions	-700000	usd
CY2021	peri	Deferred Federal Tax Adjustments Settlements And Unusual Provisions DeferredFederalTaxAdjustmentsSettlementsAndUnusualProvisions	1593000	usd
CY2023	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	19466000	usd
CY2022	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	14378000	usd
CY2021	us-gaap	Federal Income Tax Expense Benefit Continuing Operations FederalIncomeTaxExpenseBenefitContinuingOperations	8060000	usd
CY2023	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	517000	usd
CY2022	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	820000	usd
CY2021	us-gaap	Current Foreign Tax Expense Benefit CurrentForeignTaxExpenseBenefit	444000	usd
CY2023	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	860000	usd
CY2022	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-665000	usd
CY2021	us-gaap	Deferred Foreign Income Tax Expense Benefit DeferredForeignIncomeTaxExpenseBenefit	-1778000	usd
CY2023	peri	Deferred Foreign Tax Adjustments Settlements And Unusual Provisions DeferredForeignTaxAdjustmentsSettlementsAndUnusualProvisions	-565000	usd
CY2022	peri	Deferred Foreign Tax Adjustments Settlements And Unusual Provisions DeferredForeignTaxAdjustmentsSettlementsAndUnusualProvisions	-94000	usd
CY2021	peri	Deferred Foreign Tax Adjustments Settlements And Unusual Provisions DeferredForeignTaxAdjustmentsSettlementsAndUnusualProvisions	-117000	usd
CY2022	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	61000	usd
CY2021	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	-1451000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20278000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14439000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6609000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	6077000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Operating Loss Carryforwards DeferredTaxAssetsOperatingLossCarryforwards	5912000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3345000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	3520000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Deferred Expense Reserves And Accruals DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals	2943000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12942000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Gross DeferredTaxAssetsGross	12133000	usd
CY2023Q4	peri	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	-6643000	usd
CY2022Q4	peri	Deferred Tax Assets Intangible Assets DeferredTaxAssetsIntangibleAssets	-3895000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2119000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Valuation Allowance DeferredTaxAssetsValuationAllowance	2459000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4180000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5779000	usd
CY2023Q4	peri	Deferred Tax Assets And Liabilities Noncurrent DeferredTaxAssetsAndLiabilitiesNoncurrent	722000	usd
CY2022Q4	peri	Deferred Tax Assets And Liabilities Noncurrent DeferredTaxAssetsAndLiabilitiesNoncurrent	-791000	usd
CY2023Q4	peri	Deferred Tax Assets Noncurrent DeferredTaxAssetsNoncurrent	3458000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	137691000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	113664000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	45315000	usd
CY2023	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2021	us-gaap	Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate	0.23	pure
CY2023	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	31669000	usd
CY2022	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	26143000	usd
CY2021	us-gaap	Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate	10422000	usd
CY2023	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	15753000	usd
CY2022	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	11255000	usd
CY2021	us-gaap	Income Tax Reconciliation Tax Exempt Income IncomeTaxReconciliationTaxExemptIncome	5610000	usd
CY2023	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	3683000	usd
CY2022	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	-229000	usd
CY2021	us-gaap	Income Tax Reconciliation Nondeductible Expense IncomeTaxReconciliationNondeductibleExpense	710000	usd
CY2023	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	407000	usd
CY2022	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	313000	usd
CY2021	us-gaap	Income Tax Reconciliation Foreign Income Tax Rate Differential IncomeTaxReconciliationForeignIncomeTaxRateDifferential	226000	usd
CY2023	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	667000	usd
CY2022	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-55000	usd
CY2021	us-gaap	Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance	-922000	usd
CY2023	peri	Income Tax Reconciliation Future Year Income Taxes IncomeTaxReconciliationFutureYearIncomeTaxes	-340000	usd
CY2022	peri	Income Tax Reconciliation Future Year Income Taxes IncomeTaxReconciliationFutureYearIncomeTaxes	-185000	usd
CY2021	peri	Income Tax Reconciliation Future Year Income Taxes IncomeTaxReconciliationFutureYearIncomeTaxes	390000	usd
CY2023	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-97000	usd
CY2022	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-157000	usd
CY2021	us-gaap	Income Tax Reconciliation Other Adjustments IncomeTaxReconciliationOtherAdjustments	-83000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20278000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14439000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6609000	usd
CY2023	peri	Tax Benefit Per Basic Share TaxBenefitPerBasicShare	0.33
CY2022	peri	Tax Benefit Per Basic Share TaxBenefitPerBasicShare	0.25
CY2021	peri	Tax Benefit Per Basic Share TaxBenefitPerBasicShare	0.16
CY2023	peri	Tax Benefit Per Diluted Share TaxBenefitPerDilutedShare	0.31
CY2022	peri	Tax Benefit Per Diluted Share TaxBenefitPerDilutedShare	0.23
CY2021	peri	Tax Benefit Per Diluted Share TaxBenefitPerDilutedShare	0.15
CY2021	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.23	pure
CY2022	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.23	pure
CY2023	us-gaap	Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential	0.23	pure
CY2023	peri	Preferred Enterprise Tax Rate PreferredEnterpriseTaxRate	0.16	pure
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9400000	usd
CY2021Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	6928000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-755000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Period Increase Decrease UnrecognizedTaxBenefitsPeriodIncreaseDecrease	-590000	usd
CY2023	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	4077000	usd
CY2022	us-gaap	Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions	3062000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12722000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	9400000	usd
CY2023Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	910000	usd
CY2022Q4	us-gaap	Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued	975000	usd
CY2023Q4	us-gaap	Operating Loss Carryforwards OperatingLossCarryforwards	2560000	usd
CY2023Q4	us-gaap	Deferred Tax Assets Capital Loss Carryforwards DeferredTaxAssetsCapitalLossCarryforwards	1187000	usd
CY2023	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	117413000	usd
CY2022	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	99225000	usd
CY2021	us-gaap	Income Loss From Continuing Operations IncomeLossFromContinuingOperations	38706000	usd
CY2023	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	47128232	shares
CY2022	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	44871149	shares
CY2021	us-gaap	Weighted Average Number Of Shares Issued Basic WeightedAverageNumberOfSharesIssuedBasic	34397134	shares
CY2023	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	2945753	shares
CY2022	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3200489	shares
CY2021	us-gaap	Incremental Common Shares Attributable To Share Based Payment Arrangements IncrementalCommonSharesAttributableToShareBasedPaymentArrangements	3432591	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50073985	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48071638	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37829725	shares
CY2023	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.49
CY2022	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	2.21
CY2021	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	1.13
CY2023	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.34
CY2022	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	2.06
CY2021	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	1.02
CY2023	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	0	shares
CY2022	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	456696	shares
CY2021	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	1035307	shares
CY2023	us-gaap	Revenues Revenues	743155000	usd
CY2022	us-gaap	Revenues Revenues	640256000	usd
CY2021	us-gaap	Revenues Revenues	478498000	usd
CY2023Q4	us-gaap	Noncurrent Assets NoncurrentAssets	9788000	usd
CY2022Q4	us-gaap	Noncurrent Assets NoncurrentAssets	13741000	usd
CY2023	us-gaap	Lease Expiration Date1 LeaseExpirationDate1	2025-01-31
CY2023Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2022Q4	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2023	dei	Entity Central Index Key EntityCentralIndexKey	0001338940
CY2023	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	FY
CY2023	dei	Amendment Flag AmendmentFlag	false
CY2023	dei	Document Type DocumentType	20-F
CY2023	dei	Document Registration Statement DocumentRegistrationStatement	false
CY2023	dei	Document Annual Report DocumentAnnualReport	true
CY2023	dei	Document Period End Date DocumentPeriodEndDate	2023-12-31
CY2023	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--12-31
CY2023	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2023
CY2023	dei	Document Transition Report DocumentTransitionReport	false
CY2023	dei	Document Shell Company Report DocumentShellCompanyReport	false
CY2023	dei	Entity File Number EntityFileNumber	000-51694
CY2023	dei	Entity Registrant Name EntityRegistrantName	Perion Network Ltd.
CY2023	dei	Entity Address Country EntityAddressCountry	IL
CY2023	dei	Entity Address Address Line1 EntityAddressAddressLine1	26 HaRokmim Street
CY2023	dei	Entity Address City Or Town EntityAddressCityOrTown	Holon
CY2023	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	L3
CY2023	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	5885849
CY2023	dei	Security12b Title Security12bTitle	Ordinary shares, par value NIS 0.03 per share
CY2023	dei	Trading Symbol TradingSymbol	PERI
CY2023	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2023Q4	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	47991344	shares
CY2023	dei	Entity Well Known Seasoned Issuer EntityWellKnownSeasonedIssuer	Yes
CY2023	dei	Entity Voluntary Filers EntityVoluntaryFilers	No
CY2023	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2023	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2023	dei	Entity Filer Category EntityFilerCategory	Large Accelerated Filer
CY2023	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2023	dei	Icfr Auditor Attestation Flag IcfrAuditorAttestationFlag	true
CY2023	dei	Document Fin Stmt Error Correction Flag DocumentFinStmtErrorCorrectionFlag	false
CY2023	dei	Document Accounting Standard DocumentAccountingStandard	U.S. GAAP
CY2023	dei	Entity Shell Company EntityShellCompany	false
CY2023	dei	Auditor Firm AuditorFirmId	1281
CY2023	dei	Auditor Name AuditorName	KOST FORER GABBAY & KASIERER
CY2023	dei	Auditor Location AuditorLocation	Tel-Aviv, Israel
CY2023Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	187609000	usd
CY2022Q4	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	176226000	usd
CY2023Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1339000	usd
CY2022Q4	us-gaap	Restricted Cash Current RestrictedCashCurrent	1295000	usd
CY2023Q4	us-gaap	Short Term Investments ShortTermInvestments	207450000	usd
CY2022Q4	us-gaap	Short Term Investments ShortTermInvestments	253400000	usd
CY2023Q4	us-gaap	Marketable Securities MarketableSecurities	77616000	usd
CY2022Q4	us-gaap	Marketable Securities MarketableSecurities	0	usd
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2091000	usd
CY2022Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2134000	usd
CY2023Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	231539000	usd
CY2022Q4	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	160488000	usd
CY2023Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	21033000	usd
CY2022Q4	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	12049000	usd
CY2023Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	6609000	usd
CY2022Q4	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	10130000	usd
CY2023Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	88652000	usd
CY2022Q4	us-gaap	Intangible Assets Net Excluding Goodwill IntangibleAssetsNetExcludingGoodwill	51664000	usd
CY2023Q4	us-gaap	Goodwill Goodwill	247975000	usd
CY2022Q4	us-gaap	Goodwill Goodwill	195527000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4180000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5779000	usd
CY2023Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	85000	usd
CY2022Q4	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	49000	usd
CY2023Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	350680000	usd
CY2022Q4	us-gaap	Assets Noncurrent AssetsNoncurrent	266760000	usd
CY2023Q4	us-gaap	Assets Assets	1077266000	usd
CY2022Q4	us-gaap	Assets Assets	870218000	usd
CY2023Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	217181000	usd
CY2022Q4	us-gaap	Accounts Payable Current AccountsPayableCurrent	155854000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42636000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	37869000	usd
CY2023Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	4198000	usd
CY2022Q4	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	3900000	usd
CY2023Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2297000	usd
CY2022Q4	us-gaap	Deferred Revenue Current DeferredRevenueCurrent	2377000	usd
CY2023Q4	peri	Shortterm Payment Obligation Related To Acquisitions ShorttermPaymentObligationRelatedToAcquisitions	73716000	usd
CY2022Q4	peri	Shortterm Payment Obligation Related To Acquisitions ShorttermPaymentObligationRelatedToAcquisitions	34608000	usd
CY2023Q4	us-gaap	Liabilities Current LiabilitiesCurrent	340028000	usd
CY2022Q4	us-gaap	Liabilities Current LiabilitiesCurrent	234608000	usd
CY2023Q4	peri	Payment Obligation Related To Acquisition Non Current PaymentObligationRelatedToAcquisitionNonCurrent	0	usd
CY2022Q4	peri	Payment Obligation Related To Acquisition Non Current PaymentObligationRelatedToAcquisitionNonCurrent	33113000	usd
CY2023Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	3448000	usd
CY2022Q4	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	7580000	usd
CY2023Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	15643000	usd
CY2022Q4	us-gaap	Other Liabilities Noncurrent OtherLiabilitiesNoncurrent	11783000	usd
CY2023Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	19091000	usd
CY2022Q4	us-gaap	Liabilities Noncurrent LiabilitiesNoncurrent	52476000	usd
CY2023Q4	us-gaap	Liabilities Liabilities	359119000	usd
CY2022Q4	us-gaap	Liabilities Liabilities	287084000	usd
CY2022Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.03
CY2023Q4	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.03
CY2022Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2023Q4	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	80000000	shares
CY2023Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	48106683	shares
CY2022Q4	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	46287732	shares
CY2023Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	47991344	shares
CY2022Q4	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	46172393	shares
CY2023Q4	us-gaap	Common Stock Value CommonStockValue	413000	usd
CY2022Q4	us-gaap	Common Stock Value CommonStockValue	398000	usd
CY2023Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	530620000	usd
CY2022Q4	us-gaap	Additional Paid In Capital Common Stock AdditionalPaidInCapitalCommonStock	513534000	usd
CY2022Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	115339	shares
CY2023Q4	us-gaap	Treasury Stock Common Shares TreasuryStockCommonShares	115339	shares
CY2023Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1002000	usd
CY2022Q4	us-gaap	Treasury Stock Value TreasuryStockValue	1002000	usd
CY2023Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-83000	usd
CY2022Q4	us-gaap	Accumulated Other Comprehensive Income Loss Net Of Tax AccumulatedOtherComprehensiveIncomeLossNetOfTax	-582000	usd
CY2023Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	188199000	usd
CY2022Q4	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	70786000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	718147000	usd
CY2022Q4	us-gaap	Stockholders Equity StockholdersEquity	583134000	usd
CY2023Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	1077266000	usd
CY2022Q4	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	870218000	usd
CY2023	us-gaap	Revenues Revenues	743155000	usd
CY2022	us-gaap	Revenues Revenues	640256000	usd
CY2021	us-gaap	Revenues Revenues	478498000	usd
CY2023	peri	Cost Of Revenue Expense CostOfRevenueExpense	37830000	usd
CY2022	peri	Cost Of Revenue Expense CostOfRevenueExpense	30404000	usd
CY2021	peri	Cost Of Revenue Expense CostOfRevenueExpense	25197000	usd
CY2023	peri	Traffic Acquisition Costs And Media Buy TrafficAcquisitionCostsAndMediaBuy	432943000	usd
CY2022	peri	Traffic Acquisition Costs And Media Buy TrafficAcquisitionCostsAndMediaBuy	372601000	usd
CY2021	peri	Traffic Acquisition Costs And Media Buy TrafficAcquisitionCostsAndMediaBuy	288018000	usd
CY2023	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	33066000	usd
CY2022	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	34424000	usd
CY2021	us-gaap	Research And Development Expense ResearchAndDevelopmentExpense	35348000	usd
CY2023	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	57991000	usd
CY2022	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	56014000	usd
CY2021	us-gaap	Selling And Marketing Expense SellingAndMarketingExpense	53209000	usd
CY2023	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	31799000	usd
CY2022	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	27629000	usd
CY2021	us-gaap	General And Administrative Expense GeneralAndAdministrativeExpense	23179000	usd
CY2023	peri	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	18694000	usd
CY2022	peri	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-3816000	usd
CY2021	peri	Change In Fair Value Of Contingent Consideration ChangeInFairValueOfContingentConsideration	-2246000	usd
CY2023	us-gaap	Depreciation And Amortization DepreciationAndAmortization	14092000	usd
CY2022	us-gaap	Depreciation And Amortization DepreciationAndAmortization	13838000	usd
CY2021	us-gaap	Depreciation And Amortization DepreciationAndAmortization	9897000	usd
CY2023	us-gaap	Operating Expenses OperatingExpenses	626415000	usd
CY2022	us-gaap	Operating Expenses OperatingExpenses	531094000	usd
CY2021	us-gaap	Operating Expenses OperatingExpenses	432602000	usd
CY2023	us-gaap	Operating Income Loss OperatingIncomeLoss	116740000	usd
CY2022	us-gaap	Operating Income Loss OperatingIncomeLoss	109162000	usd
CY2021	us-gaap	Operating Income Loss OperatingIncomeLoss	45896000	usd
CY2023	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	20951000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4502000	usd
CY2021	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	-581000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	137691000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	113664000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	45315000	usd
CY2023	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	20278000	usd
CY2022	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	14439000	usd
CY2021	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	6609000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	117413000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	99225000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Including Portion Attributable To Noncontrolling Interest IncomeLossFromContinuingOperationsIncludingPortionAttributableToNoncontrollingInterest	38706000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.49
CY2022	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	2.21
CY2021	us-gaap	Income Loss From Continuing Operations Per Basic Share IncomeLossFromContinuingOperationsPerBasicShare	1.13
CY2023	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.34
CY2022	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	2.06
CY2021	us-gaap	Income Loss From Continuing Operations Per Diluted Share IncomeLossFromContinuingOperationsPerDilutedShare	1.02
CY2023	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	47128232	shares
CY2022	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	44871149	shares
CY2021	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	34397134	shares
CY2023	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	50073985	shares
CY2022	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	48071638	shares
CY2021	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	37829725	shares
CY2023	us-gaap	Net Income Loss NetIncomeLoss	117413000	usd
CY2022	us-gaap	Net Income Loss NetIncomeLoss	99225000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	38706000	usd
CY2023	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	154000	usd
CY2022	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-147000	usd
CY2021	us-gaap	Other Comprehensive Income Foreign Currency Transaction And Translation Adjustment Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeForeignCurrencyTransactionAndTranslationAdjustmentNetOfTaxPortionAttributableToParent	-315000	usd
CY2023	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	-101000	usd
CY2022	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	usd
CY2021	us-gaap	Marketable Securities Unrealized Gain Loss MarketableSecuritiesUnrealizedGainLoss	0	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-787000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	-1255000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax	242000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-1233000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	-948000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax	167000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	446000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	-307000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Cash Flow Hedge Gain Loss After Reclassification And Tax OtherComprehensiveIncomeLossCashFlowHedgeGainLossAfterReclassificationAndTax	75000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	499000	usd
CY2022	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-454000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-240000	usd
CY2023	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	117912000	usd
CY2022	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	98771000	usd
CY2021	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	38466000	usd
CY2020Q4	us-gaap	Stockholders Equity StockholdersEquity	184122000	usd
CY2021	us-gaap	Stock Issued During Period Value New Issues StockIssuedDuringPeriodValueNewIssues	230489000	usd
CY2021	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	6985000	usd
CY2021	us-gaap	Stock Granted During Period Value Sharebased Compensation Gross StockGrantedDuringPeriodValueSharebasedCompensationGross	6898000	usd
CY2021	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	-240000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	38706000	usd
CY2023	us-gaap	Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent	499000	usd
CY2023Q4	us-gaap	Stockholders Equity StockholdersEquity	718147000	usd
CY2021	us-gaap	Net Income Loss NetIncomeLoss	38706000	usd
CY2023	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	14092000	usd
CY2022	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	13838000	usd
CY2021	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	9897000	usd
CY2023	us-gaap	Share Based Compensation ShareBasedCompensation	15590000	usd
CY2022	us-gaap	Share Based Compensation ShareBasedCompensation	11570000	usd
CY2021	us-gaap	Share Based Compensation ShareBasedCompensation	6985000	usd
CY2023	peri	Change In Fair Value Of Payment Obligation Related To Acquisition ChangeInFairValueOfPaymentObligationRelatedToAcquisition	19251000	usd
CY2022	peri	Change In Fair Value Of Payment Obligation Related To Acquisition ChangeInFairValueOfPaymentObligationRelatedToAcquisition	-6904000	usd
CY2021	peri	Change In Fair Value Of Payment Obligation Related To Acquisition ChangeInFairValueOfPaymentObligationRelatedToAcquisition	350000	usd
CY2023	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	27000	usd
CY2022	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	-20000	usd
CY2021	us-gaap	Foreign Currency Transaction Gain Loss Before Tax ForeignCurrencyTransactionGainLossBeforeTax	223000	usd
CY2022	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	3646000	usd
CY2021	us-gaap	Increase Decrease In Accrued Interest Receivable Net IncreaseDecreaseInAccruedInterestReceivableNet	300000	usd
CY2023	peri	Deferred Income Tax Expense Benefit Cash Flow Effect DeferredIncomeTaxExpenseBenefitCashFlowEffect	-654000	usd
CY2022	peri	Deferred Income Tax Expense Benefit Cash Flow Effect DeferredIncomeTaxExpenseBenefitCashFlowEffect	-1428000	usd
CY2021	peri	Deferred Income Tax Expense Benefit Cash Flow Effect DeferredIncomeTaxExpenseBenefitCashFlowEffect	-2755000	usd
CY2023	peri	Accrued Severance Pay Net AccruedSeverancePayNet	-274000	usd
CY2022	peri	Accrued Severance Pay Net AccruedSeverancePayNet	-106000	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1147000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2023	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	27000	usd
CY2021	us-gaap	Gain Loss On Sale Of Property Plant Equipment GainLossOnSaleOfPropertyPlantEquipment	-121000	usd
CY2023	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	5329000	usd
CY2022	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	45236000	usd
CY2021	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	34239000	usd
CY2023	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	433000	usd
CY2022	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	434000	usd
CY2023	peri	Increase Decrease In Operating Lease Rightofuse Assets IncreaseDecreaseInOperatingLeaseRightofuseAssets	3653000	usd
CY2021	us-gaap	Increase Decrease In Deferred Revenue IncreaseDecreaseInDeferredRevenue	-1853000	usd
CY2023	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	155463000	usd
CY2022	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	122119000	usd
CY2021	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	71106000	usd
CY2023	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	811000	usd
CY2022	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1058000	usd
CY2021	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	627000	usd
CY2023	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	27000	usd
CY2022	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	12000	usd
CY2021	us-gaap	Proceeds From Sale Of Property Plant And Equipment ProceedsFromSaleOfPropertyPlantAndEquipment	95000	usd
CY2023	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	111026000	usd
CY2022	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2021	us-gaap	Payments To Acquire Marketable Securities PaymentsToAcquireMarketableSecurities	0	usd
CY2023	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	34427000	usd
CY2022	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2021	us-gaap	Proceeds From Sale And Maturity Of Marketable Securities ProceedsFromSaleAndMaturityOfMarketableSecurities	0	usd
CY2023	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2022	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	0	usd
CY2021	us-gaap	Proceeds From Issuance Of Private Placement ProceedsFromIssuanceOfPrivatePlacement	230489000	usd
CY2022	us-gaap	Proceeds From Stock Options Exercised ProceedsFromStockOptionsExercised	5833000	usd
CY2021	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	0	usd
CY2023	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	usd
CY2022	us-gaap	Repayments Of Long Term Lines Of Credit RepaymentsOfLongTermLinesOfCredit	0	usd
CY2021	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	4365000	usd
CY2023	peri	Creation Of Right Of Use Assets CreationOfRightOfUseAssets	132000	usd
CY2021	peri	Creation Of Right Of Use Assets CreationOfRightOfUseAssets	0	usd
CY2023	us-gaap	Use Of Estimates UseOfEstimates	<div> <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Use of estimates</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The preparation of the consolidated financial statements in conformity with U.S. Generally Accepted Accounting Principles (“GAAP”) requires management to make estimates, judgments and assumptions that affect the amounts reported and disclosed in the financial statements and the accompanying notes. Actual results could differ materially from those estimates. On an ongoing basis, the Company's management evaluates its estimates, including those related to revenue recognition, allowance for credit losses, fair value of intangible assets and goodwill, useful lives of intangible assets, contingent consideration, fair value of share-based awards, realizability of deferred tax assets, and tax uncertainties, among others. Such estimates are based on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of the Company’s assets and liabilities.</span></span></div> </div>
CY2023Q4	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2091000	usd
CY2023Q4	peri	Remaining Performance Obligations RemainingPerformanceObligations	2297000	usd
CY2023Q4	us-gaap	Deferred Revenue DeferredRevenue	2377000	usd
CY2023	us-gaap	Cost Of Goods And Services Sold Depreciation And Amortization CostOfGoodsAndServicesSoldDepreciationAndAmortization	1392000	usd
CY2021	us-gaap	Defined Contribution Plan Cost Recognized DefinedContributionPlanCostRecognized	683000	usd
CY2023	us-gaap	Concentration Risk Credit Risk ConcentrationRiskCreditRisk	<div> <div style="text-align:justify;margin-left:56.7pt;line-height:1.25;font-style:italic"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Concentrations of credit risk</span></span></div> <div style="line-height:1.25"> </div> <div style="line-height:1.25"> <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">Financial instruments, which potentially subject the Company to a concentration of credit risk, consist primarily of cash and cash equivalents, bank deposits, restricted cash and accounts receivable.</span></span></div> </div> <div style="line-height:1.25"> </div> <div style="line-height:1.25"> <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The majority of the Company’s cash and cash equivalents, bank deposits and restricted cash are invested in USD instruments with major banks in the U.S. and Israel. Generally, these deposits may be redeemed upon demand and, therefore, bear minimal risk.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The Company’s major customers are financially sound, and the Company believes low credit risk is associated with these customers. To date, the Company has not experienced any material credit losses.</span></span></div> <div style="line-height:1.25"> </div> <div style="text-align:justify;margin-left:56.7pt;line-height:1.25"><span style="font-size:10pt"><span style="font-family:Times New Roman,Times,serif">The allowance against gross trade receivables reflects the current expected credit loss inherent in the receivables portfolio determined based on the Company’s methodology. The Company’s methodology is based on historical collection experience, customer creditworthiness, current and future economic condition, and market condition. Additionally, specific allowance amounts are established to record the appropriate provision for customers that have a higher probability of default. Trade receivables are written off after all reasonable means to collect the full amount have been exhausted.</span></span></div> </div> </div>
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate	0	pure
CY2023	peri	Amount Recorded In Statement Of Income For Change In Fair Value Of Contingent Consideration AmountRecordedInStatementOfIncomeForChangeInFairValueOfContingentConsideration	2124000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Amortized Cost Basis AvailableForSaleDebtSecuritiesAmortizedCostBasis	77747000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Gain Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedGainBeforeTax	93000	usd
CY2023Q4	us-gaap	Available For Sale Debt Securities Accumulated Gross Unrealized Loss Before Tax AvailableForSaleDebtSecuritiesAccumulatedGrossUnrealizedLossBeforeTax	224000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities AvailableForSaleSecuritiesDebtSecurities	77616000	usd
CY2023Q4	us-gaap	Money Market Funds At Carrying Value MoneyMarketFundsAtCarryingValue	81429000	usd
CY2023Q4	us-gaap	Available For Sale Securities Debt Securities Current AvailableForSaleSecuritiesDebtSecuritiesCurrent	77616000	usd
CY2023Q4	us-gaap	Derivative Assets DerivativeAssets	234000	usd
CY2023Q4	us-gaap	Financial Liabilities Fair Value Disclosure FinancialLiabilitiesFairValueDisclosure	69735000	usd
CY2022Q4	us-gaap	Derivative Assets DerivativeAssets	7000	usd
CY2022Q4	us-gaap	Assets Fair Value Disclosure AssetsFairValueDisclosure	7000	usd
CY2022Q4	us-gaap	Derivative Liabilities DerivativeLiabilities	239000	usd
CY2022Q4	peri	Fair Value Liabilities Measured On Recurring Basis Contingent Consideration In Connection To Acquisitions FairValueLiabilitiesMeasuredOnRecurringBasisContingentConsiderationInConnectionToAcquisitions	63695000	usd
CY2022Q4	peri	Fair Value Liabilities Measured On Recurring Basis Contingent Consideration In Connection To Acquisitions FairValueLiabilitiesMeasuredOnRecurringBasisContingentConsiderationInConnectionToAcquisitions	63695000	usd
CY2023	us-gaap	Payment For Contingent Consideration Liability Financing Activities PaymentForContingentConsiderationLiabilityFinancingActivities	13256000	usd
CY2023	peri	Changes In Fair Value Of Contingent Consideration ChangesInFairValueOfContingentConsideration	18694000	usd
CY2023	peri	Revaluation Of Acquisition Related Contingent Consideration RevaluationOfAcquisitionRelatedContingentConsideration	582000	usd
CY2023Q4	peri	Fair Value Liabilities Measured On Recurring Basis Contingent Consideration In Connection To Acquisitions FairValueLiabilitiesMeasuredOnRecurringBasisContingentConsiderationInConnectionToAcquisitions	69715000	usd
CY2023Q4	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	28407000	usd
CY2023	us-gaap	Depreciation Depreciation	1644000	usd
CY2022	us-gaap	Depreciation Depreciation	1954000	usd
CY2021	us-gaap	Depreciation Depreciation	3022000	usd
CY2021Q4	us-gaap	Goodwill Goodwill	189265000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	88652000	usd
CY2021Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	56700000	usd
CY2022	peri	Finite Lived Intangible Assets Net Acquired During Period FiniteLivedIntangibleAssetsNetAcquiredDuringPeriod	6848000	usd
CY2022	peri	Finite Lived Intangible Assets Net Amortization FiniteLivedIntangibleAssetsNetAmortization	11884000	usd
CY2022Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	51664000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Next Twelve Months FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths	16946000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Amortization Expense Year Five FiniteLivedIntangibleAssetsAmortizationExpenseYearFive	10691000	usd
CY2023Q4	us-gaap	Finite Lived Intangible Assets Net FiniteLivedIntangibleAssetsNet	88652000	usd
CY2023Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	23292000	usd
CY2022Q4	us-gaap	Accrued Salaries Current AccruedSalariesCurrent	20788000	usd
CY2023Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	10808000	usd
CY2022Q4	us-gaap	Accounts Payable Other Current AccountsPayableOtherCurrent	10758000	usd
CY2023Q4	peri	Accrued Expenses AccruedExpenses	7702000	usd
CY2022Q4	peri	Accrued Expenses AccruedExpenses	5185000	usd
CY2023Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	834000	usd
CY2022Q4	us-gaap	Other Accrued Liabilities Current OtherAccruedLiabilitiesCurrent	1138000	usd
CY2023Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	42636000	usd
CY2022Q4	us-gaap	Accrued Liabilities Current AccruedLiabilitiesCurrent	37869000	usd
CY2023	peri	Number Of Periods In Additional Lease NumberOfPeriodsInAdditionalLease	P24M
CY2022Q4	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P2Y11M8D
CY2022Q4	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.0523	pure
CY2023Q4	us-gaap	Lessee Operating Lease Liability Payments Due Year Two LesseeOperatingLeaseLiabilityPaymentsDueYearTwo	2851000	usd
CY2022	peri	Cash Paid For Measurement Of Lease Liabilities CashPaidForMeasurementOfLeaseLiabilities	5880000	usd
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice	1.39
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2 SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2	P59Y8M12D
CY2022Q4	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue	73284000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod	1276693	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice	0.01
CY2023	us-gaap	Stock Issued During Period Shares Stock Options Exercised StockIssuedDuringPeriodSharesStockOptionsExercised	1586980	shares
CY2023	us-gaap	Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice	1.33
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue	50903000	usd
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Expirations In Period ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExpirationsInPeriod	261106	shares
CY2023	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	35.65
CY2022	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	20.13
CY2021	us-gaap	Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue	18.55
CY2023	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	11531
CY2022	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	10008
CY2021	us-gaap	Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Weighted Average Grant Date Fair Value SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedWeightedAverageGrantDateFairValue	4137
CY2023	us-gaap	Allocated Share Based Compensation Expense AllocatedShareBasedCompensationExpense	15590000	usd
CY2023	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	1147000	usd
CY2022	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2021	us-gaap	Accretion Amortization Of Discounts And Premiums Investments AccretionAmortizationOfDiscountsAndPremiumsInvestments	0	usd
CY2021	us-gaap	Other Nonoperating Income OtherNonoperatingIncome	539000	usd
CY2022	us-gaap	Nonoperating Income Expense NonoperatingIncomeExpense	4502000	usd
CY2022	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	7030000	usd
CY2021	us-gaap	Income Loss From Continuing Operations Before Income Taxes Foreign IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign	6461000	usd
CY2023	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	137691000	usd
CY2021	us-gaap	Current Income Tax Expense Benefit CurrentIncomeTaxExpenseBenefit	7891000	usd
CY2023	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-734000	usd
CY2022	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-1525000	usd
CY2021	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-2758000	usd
CY2023	us-gaap	Current Federal Tax Expense Benefit CurrentFederalTaxExpenseBenefit	21106000	usd
CY2023	us-gaap	Foreign Income Tax Expense Benefit Continuing Operations ForeignIncomeTaxExpenseBenefitContinuingOperations	812000	usd
CY2022Q4	us-gaap	Deferred Tax Assets Tax Credit Carryforwards Research DeferredTaxAssetsTaxCreditCarryforwardsResearch	3278000	usd
CY2023Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	6643000	usd
CY2022Q4	us-gaap	Deferred Income Tax Liabilities Net DeferredIncomeTaxLiabilitiesNet	3895000	usd
CY2022Q4	peri	Deferred Tax Assets Noncurrent DeferredTaxAssetsNoncurrent	6570000	usd
CY2023Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	4180000	usd
CY2022Q4	us-gaap	Deferred Income Tax Assets Net DeferredIncomeTaxAssetsNet	5779000	usd
CY2022	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	185000	usd
CY2023	us-gaap	Valuation Allowance Deferred Tax Asset Change In Amount ValuationAllowanceDeferredTaxAssetChangeInAmount	340000	usd
CY2023	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	42000	usd
CY2022	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	-136000	usd
CY2021	us-gaap	Income Tax Reconciliation Prior Year Income Taxes IncomeTaxReconciliationPriorYearIncomeTaxes	1476000	usd
CY2023	peri	Description Of New Technological Enterprise Incentives Regime DescriptionOfNewTechnologicalEnterpriseIncentivesRegime	According to Amendment 73, a Preferred Technological Enterprise, as defined in Amendment 73, with total consolidated revenue of less than NIS 10 billion, shall be subject to 12% tax rate on income derived from intellectual property (in development area A—a tax rate of 7.5%). In order to qualify as a Preferred Technological Enterprise certain criteria must be met, such as a minimum ratio of annual R&D expenditure and R&D employees, as well as having at least 25% of annual revenue derived from exports.
CY2023Q4	peri	Dividends Distributed From Income From Preferred Technological Enterprises DividendsDistributedFromIncomeFromPreferredTechnologicalEnterprises	0.20	pure
CY2023Q4	peri	Dividend Distributed To Foreign Corporate Shareholder If Percentage Of Foreign Shareholders Exceeds90 DividendDistributedToForeignCorporateShareholderIfPercentageOfForeignShareholdersExceeds90	0.04	pure
CY2023Q4	us-gaap	Unrecognized Tax Benefits UnrecognizedTaxBenefits	12722000	usd
CY2023Q4	peri	Recognized Tax Benefit RecognizedTaxBenefit	11972000	usd
CY2023	us-gaap	Number Of Operating Segments NumberOfOperatingSegments	1000	segment

Files In Submission

Name	View Source	Status
0001178913-24-001251-index-headers.html	Edgar Link	pending
0001178913-24-001251-index.html	Edgar Link	pending
0001178913-24-001251.txt	Edgar Link	pending
0001178913-24-001251-xbrl.zip	Edgar Link	pending
exhibit_12-1.htm	Edgar Link	pending
exhibit_12-2.htm	Edgar Link	pending
exhibit_13-1.htm	Edgar Link	pending
exhibit_13-2.htm	Edgar Link	pending
exhibit_15-1.htm	Edgar Link	pending
exhibit_2-1.htm	Edgar Link	pending
exhibit_8-1.htm	Edgar Link	pending
exhibit_97-1.htm	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
image01.jpg	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
peri-20231231.xsd	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
peri-20231231_cal.xml	Edgar Link	unprocessable
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R44.htm	Edgar Link	pending
R45.htm	Edgar Link	pending
R46.htm	Edgar Link	pending
R47.htm	Edgar Link	pending
R48.htm	Edgar Link	pending
R49.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R50.htm	Edgar Link	pending
R51.htm	Edgar Link	pending
R52.htm	Edgar Link	pending
R53.htm	Edgar Link	pending
R54.htm	Edgar Link	pending
R55.htm	Edgar Link	pending
R56.htm	Edgar Link	pending
R57.htm	Edgar Link	pending
R58.htm	Edgar Link	pending
R59.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R60.htm	Edgar Link	pending
R61.htm	Edgar Link	pending
R62.htm	Edgar Link	pending
R63.htm	Edgar Link	pending
R64.htm	Edgar Link	pending
R65.htm	Edgar Link	pending
R66.htm	Edgar Link	pending
R67.htm	Edgar Link	pending
R68.htm	Edgar Link	pending
R69.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R70.htm	Edgar Link	pending
R71.htm	Edgar Link	pending
R72.htm	Edgar Link	pending
R73.htm	Edgar Link	pending
R74.htm	Edgar Link	pending
R75.htm	Edgar Link	pending
R76.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
zk2431117.htm	Edgar Link	pending
FilingSummary.xml	Edgar Link	unprocessable
peri-20231231_def.xml	Edgar Link	unprocessable
peri-20231231_lab.xml	Edgar Link	unprocessable
peri-20231231_pre.xml	Edgar Link	unprocessable
zk2431117_htm.xml	Edgar Link	completed

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$PERI
Perion Network Ltd Stock $peri

2023 Q4 Form 20-F Financial Statement

#000117891324001251 Filed on April 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PERI Perion Network Ltd Stock $peri

2023 Q4 Form 20-F Financial Statement

#000117891324001251 Filed on April 08, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$PERI
Perion Network Ltd Stock $peri